Guardant Days Of Sales Outstanding from 2010 to 2025

GH Stock  USD 43.21  1.94  4.30%   
Guardant Health's Days Of Sales Outstanding is increasing with slightly volatile movements from year to year. Days Of Sales Outstanding is estimated to finish at 88.45 this year. For the period between 2010 and 2025, Guardant Health, Days Of Sales Outstanding quarterly trend regression had mean deviation of  20.45 and range of 93.1986. View All Fundamentals
 
Days Of Sales Outstanding  
First Reported
2010-12-31
Previous Quarter
54.45395634
Current Value
88.45
Quarterly Volatility
26.14534737
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Guardant Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Guardant Health's main balance sheet or income statement drivers, such as Tax Provision of 1.3 M, Net Interest Income of 53.7 M or Interest Income of 56.4 M, as well as many indicators such as Price To Sales Ratio of 4.82, Dividend Yield of 0.0022 or Days Sales Outstanding of 88.45. Guardant financial statements analysis is a perfect complement when working with Guardant Health Valuation or Volatility modules.
  
Check out the analysis of Guardant Health Correlation against competitors.
For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.

Latest Guardant Health's Days Of Sales Outstanding Growth Pattern

Below is the plot of the Days Of Sales Outstanding of Guardant Health over the last few years. It is Guardant Health's Days Of Sales Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Guardant Health's overall financial position and show how it may be relating to other accounts over time.
Days Of Sales Outstanding10 Years Trend
Slightly volatile
   Days Of Sales Outstanding   
       Timeline  

Guardant Days Of Sales Outstanding Regression Statistics

Arithmetic Mean69.71
Geometric Mean66.03
Coefficient Of Variation37.51
Mean Deviation20.45
Median57.46
Standard Deviation26.15
Sample Variance683.58
Range93.1986
R-Value0.40
Mean Square Error614.77
R-Squared0.16
Significance0.12
Slope2.20
Total Sum of Squares10,254

Guardant Days Of Sales Outstanding History

2025 88.45
2024 54.45
2023 57.46
2022 78.97
2021 95.39
2020 67.85
2019 81.7

About Guardant Health Financial Statements

Investors use fundamental indicators, such as Guardant Health's Days Of Sales Outstanding, to determine how well the company is positioned to perform in the future. Although Guardant Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Days Of Sales Outstanding 54.45  88.45 

Currently Active Assets on Macroaxis

Check out the analysis of Guardant Health Correlation against competitors.
For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.56)
Revenue Per Share
6.021
Quarterly Revenue Growth
0.302
Return On Assets
(0.17)
Return On Equity
(45.84)
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.